When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMGN - Mirati Therapeutics: Updates To Thesis ASCO Winner Sans Data
Amgen Inc.
Shares of Mirati Therapeutics (MRTX) have risen by over 800% since my September 2017 article called the stock a Buy and noted it was poised to capitalize on the emerging theme of targeted oncology (much like prior picks in the space Loxo Oncology and Ignyta). A couple months later, I encouraged readers to "Buy the Dip" after the stock corrected on news that management was de-prioritizing glesatinib in favor of freeing up cash to push forward sitravatinib and its preclinical KRAS program.
Given that the targeted oncology theme shows little sign